|
Ambarella, Inc. (AMBA): BCG Matrix [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Ambarella, Inc. (AMBA) Bundle
You're looking at Ambarella, Inc.'s portfolio right now, and the picture is one of a company in a critical pivot: the established CV2 line is still printing money-delivering 60.9% gross margins and $34.3 million in Q3 FY2026 operating cash flow-but the future hinges on the new Stars like CV5/CV7, which already account for 80% of Q3 FY2026 revenue and are fueling a raised guidance to a $390 million midpoint. Still, you have to watch the big bets, like the CV3-AD autonomous driving chips, which are burning R&D cash while trying to capture a massive market. Let's map this transition clearly using the four quadrants to see exactly where to place your focus below.
Background of Ambarella, Inc. (AMBA)
You're looking at Ambarella, Inc. (AMBA) as of late 2025, and the story is one of a semiconductor company firmly pivoting toward the Edge AI market. Ambarella, Inc. develops system-on-chips that focus on artificial intelligence processing, advanced image signal processing, and high-definition video compression. This focus has led to significant recent financial momentum, which is what we need to understand before diving into the BCG Matrix.
For the third quarter of fiscal year 2026, which concluded around October 31, 2025, Ambarella, Inc. posted record quarterly revenue of $108.5 million, marking a 31.2% year-over-year increase. This strong top-line performance pushed the trailing twelve months (TTM) revenue up to $373.85 million, representing a 48.08% increase over the prior TTM period. The company has been consistently beating expectations; for instance, the Q3 non-GAAP earnings per share came in at $0.27, significantly ahead of the consensus estimate of $0.21.
The core of Ambarella, Inc.'s current success is its Edge AI segment. Edge AI products, defined as those integrating their proprietary deep learning AI accelerator, accounted for approximately 80% of total revenue in the third quarter of fiscal 2026. This segment is being driven by applications in enterprise security, portable video-including action and body-worn cameras-and the start of high-volume shipments into the aerial drone market. The company expects its CV2, CV5, and CV7 system-on-chips to be major revenue drivers throughout fiscal year 2026.
While the Edge AI/IoT focus is clearly leading the charge, the automotive segment is still a focus area, though its sequential revenue growth in Q3 was only in the low single digits. In fact, KeyBanc noted that 12 of the 15 new design wins announced recently were in the Edge/IoT segment rather than automotive, showing where the immediate traction lies. Management has raised the full fiscal year 2026 revenue growth guidance to a range of 36% to 38%, projecting an all-time record revenue near $390 million at the midpoint.
Financially, the company shows resilience in liquidity, with cash and marketable securities reaching $295.3 million at the end of Q3 FY2026, and a very low total debt to equity ratio of just 0.01. However, profitability remains a near-term challenge; the EBIT margin stood at -33%, reflecting operating losses, though the non-GAAP net income for Q3 was positive at $11.9 million. You should also note the significant customer concentration: one logistics partner, WT Microelectronics, accounted for 70.2% of the third-quarter revenue.
Ambarella, Inc. (AMBA) - BCG Matrix: Stars
You're looking at the engine room of Ambarella, Inc.'s current growth, which is definitely the Star quadrant of the BCG Matrix. These are the products with high market share in markets that are still expanding rapidly, meaning they need cash to fuel that growth but are also the future Cash Cows if the market matures favorably.
The core Edge AI business is the clear leader here, fueling the raised fiscal year 2026 revenue guidance midpoint to $390 million. This new guidance projects an all-time fiscal year revenue record, representing an expected growth range of 36% to 38% year-over-year. Honestly, this acceleration from the prior guidance range of 31% to 35% shows the momentum you're seeing in the market.
The products driving this are your advanced Edge AI SoCs, like the CV5 and CV7 series. Edge AI revenue set its sixth consecutive record in Q3 FY2026, making up about 80% of total revenue for that quarter. Plus, the value you're capturing per sale is increasing, which is a great sign for long-term profitability.
Here's a quick look at the financial performance supporting this Star positioning in Q3 FY2026:
| Metric | Value | Context |
| Q3 FY2026 Revenue | $108.5 million | Record quarterly revenue, up 31.2% year-over-year. |
| SoC Blended ASP Growth | Up about 20% year-over-year | Driven by the mix of advanced AI chips. |
| Edge AI Revenue Contribution | About 80% of total revenue | Sixth consecutive quarter of record Edge AI revenue. |
| Advanced Node Revenue Mix | More than 45% of Q3 revenue | From 5-nanometer based products. |
The high blended Average Selling Price (ASP) growth, up about 20% year-over-year in Q3 FY2026, is directly tied to the adoption of these advanced AI chips. You're seeing this play out across key segments, which is why the business unit performance looks so strong.
The momentum in specific IoT areas is particularly noteworthy, showing the market share gains you're making in high-growth niches. You can see the sequential strength here:
- IoT revenue grew in the mid-teens sequentially in Q3 FY2026.
- This IoT growth was led by adoption in enterprise security and portable video applications.
- Automotive revenue increased in the low single digits sequentially.
To be fair, Stars consume a lot of cash to maintain that high growth and market leadership. While Q3 non-GAAP gross margin was 60.9%, the company is still investing heavily in R&D to keep that lead. Still, the year-to-date free-cash-flow at 14.8% of revenue shows you're generating enough to fund a good chunk of that investment internally, and cash reserves stood at $295.3 million at the end of the quarter.
Finance: draft the Q4 cash flow projection, focusing on R&D spend relative to the new FY2026 revenue target of $390 million by Monday.
Ambarella, Inc. (AMBA) - BCG Matrix: Cash Cows
You're looking at the core engine of Ambarella, Inc. (AMBA) right now-the established product lines that fund the future. These Cash Cows operate in mature segments where market share is hard-won and defending it is key. The established CV2 family of computer vision SoCs (Systems-on-a-Chip) in the security market is the prime example here. This older product line represented approximately 60% of Ambarella, Inc.'s total revenue for fiscal year 2024, giving the company a very stable revenue base to work from.
This high market share in a steady segment translates directly to solid profitability, which is what you want from a Cash Cow. For the third quarter of fiscal year 2026, Ambarella, Inc. reported a non-GAAP gross margin of 60.9%. That margin shows they are effectively managing the cost of goods sold on these mature, high-volume parts, meaning a healthy profit dollar flows to the bottom line from every sale. Honestly, maintaining margins near 61% while investing heavily elsewhere is a sign of strong operational discipline.
The real value of these units is the cash they generate, which Ambarella, Inc. is clearly using to fuel its next-generation development. For the nine months leading up to Q3 FY2026, the company reported year-to-date free cash flow at 14.8% of revenue. This cash flow is critical; it helps cover the general administrative costs and, importantly, funds the high research and development spend required for the newer AI products. Furthermore, the balance sheet reflects this strength, with cash reserves standing at $295.3 million as of the Q3 FY2026 report. You want to see that cash generation because it means less reliance on external financing for innovation.
Here's a quick look at the key established product line metrics supporting this Cash Cow status:
| Metric | Value | Period/Context |
| CV2 Family Revenue Contribution | 60% | Fiscal Year 2024 |
| Non-GAAP Gross Margin | 60.9% | Q3 Fiscal Year 2026 |
| Year-to-Date Free Cash Flow Margin | 14.8% | Nine Months Ended October 31, 2025 |
| Total Cash Reserves | $295.3 million | As of Q3 Fiscal Year 2026 |
These established products fit the classic Cash Cow profile because they dominate a mature market and require minimal new investment for growth, allowing them to generate surplus cash. You can see this reflected in their characteristics:
- High market share in a mature segment.
- Generate more cash than they consume.
- Profitability supported by high margins, like 60.9% non-GAAP gross margin.
- Low investment needed for maintenance.
- Provide capital for Question Marks and Stars.
Finance: draft the next quarter's cash flow projection based on sustained 14.8% FCF margin by Friday.
Ambarella, Inc. (AMBA) - BCG Matrix: Dogs
You're looking at the segment of Ambarella, Inc.'s portfolio that represents its past, the legacy, non-AI video processing SoCs from the pre-CVflow era. These are the units with low relative market share in markets that are now low growth because the industry has moved toward AI acceleration. Honestly, these chips require minimal new investment because the capital is flowing to the AI platforms, which is the right call for a company making this kind of strategic pivot.
The data clearly shows the shift. For the fiscal year ended January 31, 2025, Ambarella, Inc. reported total revenue of $284.9 million. By the third quarter of fiscal year 2026 (ending October 31, 2025), the Edge AI products, which are the Stars/Cash Cows, accounted for approximately 80% of total revenue. This leaves the legacy products-the Dogs-to represent the remaining, significantly smaller portion of the revenue base.
Here's a quick look at how the revenue composition for the fiscal year ended January 31, 2025, breaks down, illustrating the dominance of the AI segment over the legacy segment:
| Product Segment Category | Revenue Contribution (Implied/Stated) | Fiscal Year 2025 Revenue (Approximate) |
| Edge AI Products (CVflow/HAI) | >70% of Total Revenue | $200 million to $235 million |
| Legacy/Non-AI Video Processing (Dogs) | Implied Remainder (<30%) | Implied Remainder: $50 million to $85 million |
These older chips are in highly commoditized consumer electronics and older security camera markets. They face intense competition, particularly from lower-cost Chinese rivals, which keeps their pricing power and margins thin. They are candidates for divestiture because they don't consume much cash, but they also don't generate meaningful returns relative to the focus on the AI roadmap.
- Legacy, non-AI video processing SoCs.
- Older, lower-resolution chips in consumer electronics.
- Products with minimal differentiation.
- Require little new capital investment.
- Face intense competition from lower-cost rivals.
For the fiscal year ended January 31, 2025, the non-GAAP net loss for Ambarella, Inc. was $6.8 million, a significant improvement from the $33.1 million non-GAAP net loss in fiscal year 2024. While this improvement is driven by the AI segment's growth, the Dogs segment contributes little to covering the remaining operating expenses, which were $55.3 million in Q3 FY2026.
Ambarella, Inc. (AMBA) - BCG Matrix: Question Marks
You're looking at Ambarella, Inc.'s (AMBA) newest bets-the products that are in high-growth markets but haven't yet captured significant revenue share. These are the classic Question Marks: they burn cash today because they require heavy investment to scale, but they hold the potential to become tomorrow's Stars.
The two primary candidates for this quadrant are the next-generation automotive platform and the new Generative AI silicon family. Both target massive, expanding markets, but their revenue ramp is just beginning, meaning they are currently cash consumers.
CV3-AD Family: The Autonomous Driving Ramp
The CV3-AD family for Level 2+ and higher autonomous driving (AD) systems is Ambarella, Inc.'s play in the future of mobility. While the CV2 family was expected to drive Fiscal Year 2024 revenue, the CV3 platform is the long-term automotive anchor. You need to understand that production revenue from the CV3 platform was anticipated to begin in calendar year 2026, meaning Fiscal Year 2025 and early Fiscal Year 2026 are the critical investment years before that revenue materializes. Still, you saw early validation, with Kodiak Robotics selecting the CV3-AD685 AI domain controller for its next-generation autonomous vehicles.
The price points for the CV3 family of SoCs, as previously indicated, range from $50 to more than $400 per SoC. The success here depends on converting design wins into high-volume production, which is the make-or-break moment for any Question Mark.
N1 SoC: The Edge Generative AI Push
The new focus on Generative AI (GenAI) and Large Language Model (LLM) inferencing, spearheaded by the N1 SoC, is another significant investment area. Ambarella, Inc. unveiled the N1-655 edge GenAI SoC at CES 2025, explicitly targeting industrial robotics and edge AI servers. This product is designed to bring high-performance GenAI to power- and cost-constrained edge applications, directly challenging cloud-based processing.
Here are the key specifications showing why this is a high-potential, high-investment area:
- Supports popular LLMs like Phi, Gemma, and Llama.
- Consumes only 20 watts of power.
- Enables on-chip decode of 12x simultaneous 1080p30 video streams.
- Offers 10-100x lower power consumption than cloud processors.
To help customers adopt this, Ambarella, Inc. expanded its developer ecosystem with the Cooper Pro developer kit, which began shipping after CES 2025. This investment in developer tools is essential to gain market share quickly.
Cash Consumption and Investment Required
These growth initiatives are clearly reflected in the operating expenses. You can see the cash burn required to fund the R&D for these future revenue drivers. For instance, in the third quarter of Fiscal Year 2026 (ended October 31, 2025), the non-GAAP operating expense was $55.3 million. This is a substantial outlay when compared to the revenue generated in that same period, which was $108.5 million.
To give you a clearer picture of the ongoing investment load, look at the recent expense trends:
| Period | Non-GAAP Operating Expense | Context |
|---|---|---|
| Q1 FY2026 (ended Apr 30, 2025) | $51.8 million | Slightly above guidance due to higher engineering costs on new chip development. |
| Q3 FY2026 (ended Oct 31, 2025) | $55.3 million | Reported actual expense for the quarter. |
| Q4 FY2026 Guidance (ending Jan 31, 2026) | $55.0 million to $58.0 million | Projected expense range for the following quarter. |
The strategy here is clear: Ambarella, Inc. is pouring capital into these areas because the market growth prospects are high. The overall Fiscal Year 2026 revenue growth is anticipated to be in the range of 19% to 25%, which suggests the market is responding, but the company must now execute flawlessly to convert these Question Marks into Stars. If adoption lags, these high-cost R&D centers will quickly become Dogs.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.